Journal of Histochemistry and Cytochemistry Priciples for Free Access to Science
  Search:   
    >> Advanced Search

Guidelines | Subscriptions | About | exPRESS - Current - Archive | Business Information | Contact
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Torres–Montaner, A.
Right arrow Articles by Valdivia, M. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Torres–Montaner, A.
Right arrow Articles by Valdivia, M. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Journal of Histochemistry and Cytochemistry, Vol. 48, 1521-1530, November 2000, Copyright © 2000, The Histochemical Society, Inc.


ARTICLE

Immunohistochemical Detection of Ribosomal Transcription Factor UBF and AgNOR Staining Identify Apoptotic Events in Neoplastic Cells of Hodgkin's Disease and in Other Lymphoid Cells

Antonio Torres–Montanera, Jorge Bolívard, Antonio Astolad, Jose A. Gimenez–Masb, Jose A. Brievac, and Manuel M. Valdiviad
a Servicio de Anatomía Patológica, Hospital Universitario de Puerto Real, Cádiz, Spain
b Servicio de Anatomia Patológica, Hospital Miguel Servet, Zaragoza, Spain
c Servicio de Inmunología, Hospital Puerta del Mar, Cádiz, Spain
d Departamento de Bioquímica y Biología Molecular, Facultad de Ciencias, Universidad de Cádiz, Cádiz, Spain

Correspondence to: Antonio Torres–Montaner, Servicio de Anatomía Patológica, Hospital Universitario de Puerto Real, C/ Nacional IV, km 665, 11510 Puerto Real, Cádiz, Spain.

Ribosomal RNA synthesis is a key molecular process for understanding the mechanisms that drive cell proliferation. In this process, the upstream binding factor (UBF) is involved in regulating rDNA transcription at the nucleolus, together with RNA polymerase I. Recently, UBF was demonstrated to be a substrate for selective cleavage by specific proteases during apoptosis. Here we studied the expression of UBF in several cases of Hodgkin's disease (HD) by immunostaining and found it to be absent or clearly diminished in a high proportion of Reed–Sternberg cells and Hodgkin cells compared to small reactive lymphocytes. This result contrasted with labeling of those cells by the AgNOR technique, a marker of cell proliferation dependent on increased amounts of several proteins related to ribosome assembly. Disappearance of UBF and preservation of other NOR proteins is consistent with the pattern of selective proteolysis by caspases described in early stages of apoptosis. This correlates well with our results observed on induction of apoptosis in Jurkat cells treated with anti-FAS/APO-1 serum and with those in aged germinal center B-cells, in which UBF was no longer seen although the staining signal of other NOR proteins was maintained. These results support the concept that the rate of apoptosis is higher in neoplastic cells of HD than in the benign reactive lymphocyte population. Differential proteolysis of NOR proteins, as revealed by double staining of UBF and AgNOR, may prove valuable for identification of early stages of apoptosis in cytological and histopathological samples. (J Histochem Cytochem 48:1521–1529, 2000)

Key Words: UBF, NOR, apoptosis, Reed–Sternberg cell


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





Guidelines | Subscriptions | About | exPRESS - Current - Archive | Business Information | Contact
The Journal of Histochemistry & Cytochemistry is owned, published, and licensed by The Histochemical Society © 2000